scholarly journals Decline in ethical concerns about reproductive technologies among a representative sample of US women

2016 ◽  
Vol 26 (7) ◽  
pp. 789-805 ◽  
Author(s):  
Arthur L. Greil ◽  
Kathleen S. Slauson-Blevins ◽  
Karina M. Shreffler ◽  
Katherine M. Johnson ◽  
Michelle H. Lowry ◽  
...  
Keyword(s):  
Assisted Reproductive Technology ◽  
National Survey ◽  
Representative Sample ◽  
Public Awareness ◽  
Reproductive Technologies ◽  
Reproductive Technology ◽  
Third Party ◽  
Ethical Concerns ◽  
Over Time

Public awareness and utilization of assisted reproductive technology has been increasing, but little is known about changes in ethical concerns over time. The National Survey of Fertility Barriers, a national, probability-based sample of US women, asked 2031 women the same set of questions about ethical concerns regarding six reproductive technologies on two separate occasions approximately 3 years apart. At Wave 1 (2004–2007), women had more concerns about treatments entailing the involvement of a third party than about treatments that did not. Ethical concerns declined between Wave 1 and Wave 2, but they declined faster for treatments entailing the involvement of a third party. Ethical concerns declined faster for women with greater levels of concern at Wave 1. Initial ethical concerns were higher, and there was less of a decline in ethical concerns for women with higher initial levels of religiosity.

scholarly journals Significance of disorders of proteomic profile of follicular fluid for predicting the effectiveness of in vitro fertilisation in women with infertility

2018 ◽  
Vol 99 (3) ◽  
pp. 496-503
Author(s):  
O S Zolotykh ◽  
S V Lomteva ◽  
K Yu Sagamonova
Keyword(s):  
Assisted Reproductive Technology ◽  
Follicular Fluid ◽  
Molecular Mechanisms ◽  
Reproductive Technologies ◽  
Reproductive Technology ◽  
In Vitro Fertilisation ◽  
Proteomic Profile ◽  
Technology Programs ◽  
Group 2

Aim. To study the proteomic profile of follicular fluid in patients with infertility in assisted reproductive technology programs. Methods. The study included women with infertility included in assisted reproductive technology programs: 15 women who had in vitro fertilisation which resulted in pregnancy (group 1) and 16 women with a negative result of this program (group 2). Fractionation of the follicular fluid samples was performed using the sets of special magnetic beads. Proteomic profiling was performed by tandem MALDI-mass-spectrometry. The anti-Müllerian hormone level was measured by ELISA. Results. The study revealed differences in the detectability of follicular fluid proteins with different regulatory properties in patients of groups 1 and 2. With the negative outcome of in vitro fertilisation, expression of a number of proteins involved in the processes of folliculogenesis, ovulation, selection of the dominant follicle, as well as proteins necessary for the development of the zygote and blastula was reduced in females' follicular fluid. Increased expression in women from group 2 was registered for proteins enhancing proteolytic reactions, cell apoptosis, including oocytes, which disrupt the positive action of activin and damage structural and functional state of mitochondria. A definite relationship was found between the level of anti-Müllerian hormone and rate of detection of a number of proteins, in particular protocadherin-2α, cystatin C, betaglycan, prostatic acid phosphatase, and dermicidin. Conclusion. The revealed changes in proteomic profile of the follicular fluid obviously play an important role in the molecular mechanisms that determine the effectiveness of assisted reproductive technologies; the identified differentially expressed proteins can serve as objective markers for predicting the outcomes of in vitro fertilisation.

scholarly journals Does the Human Assisted Reproductive Technology Act 2004 need a review?

2021 ◽  
Vol 17 (1) ◽  
Author(s):  
Michael Legge ◽  
Ruth Fitzgerald
Keyword(s):  
New Zealand ◽  
Assisted Reproductive Technology ◽  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
Reproductive Technology ◽  
Good Coverage

The use of assisted reproductive technologies (ART) in New Zealand is governed by the Human Assisted Reproductive Technology Act 2004 (the HART Act), which provides for all procedures currently undertaken by fertility clinics and other centres involved with ART. Although the Act has provided good coverage for the use of ART over the last 16 years, it did not have a revision clause. Here, we explore whether the HART Act should be reviewed, and outline the important considerations that need to be taken into account to ensure that the legislation is up to date with current issues and technologies.

The Birth of Assisted Reproductive Technology in China

Good Quality ◽  
2018 ◽  
Author(s):  
Ayo Wahlberg
Keyword(s):  
Family Planning ◽  
Assisted Reproductive Technology ◽  
Birth Control ◽  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
Reproductive Technology ◽  
The Core ◽  
Sperm Banks ◽  
Population Quality

This chapter chronicles the difficult birth of assisted reproductive technologies (ARTs) in China through the 1980s and 1990s, showing how ideas of improving population quality acted as a persuasive alibi for those pioneers working to develop fertility technologies under crude conditions and at a time when contraception rather than conception was at the core of family planning. From difficult beginnings in the 1980s and following legalization in 2003, ARTs have now settled firmly within China’s restrictive reproductive complex as technologies of birth control—which, in turn, has allowed it to grow into a thriving, sector as China is now home to some of the world’s largest fertility clinics and sperm banks.

Assisted Reproductive Technology in Spain: Considering Women's Interests

2009 ◽  
Vol 18 (3) ◽  
pp. 228-235 ◽  
Author(s):  
INMACULADA DE MELO-MARTÍN
Keyword(s):  
Assisted Reproductive Technology ◽  
Assisted Reproductive Technologies ◽  
Reproductive Technologies ◽  
Reproductive Technology ◽  
Assisted Conception ◽  
National Healthcare ◽  
The World ◽  
National Healthcare System ◽  
The Subject ◽  
Catholic Tradition

It might come as a surprise to many that Spain, a country with a strong Catholic tradition that officially banned contraceptive technologies until 1978, has some of the most liberal regulations in assisted reproduction in the world. Law No. 35/1988 was one of the first and most detailed acts of legislation undertaken on the subject of assisted-conception procedures. Indeed, not only did the law permit research on nonviable embryos, it made assisted reproductive technologies available to any woman, whether married or not, through the national healthcare system.

Sign in / Sign up

Export Citation Format

Share Document